Project Moray

Moray Medical, formerly known as Project Moray, was a private medtech company developing microfluidic robotic catheter technology for minimally invasive structural heart procedures. Its lead product was a robotic delivery system intended to improve precision and ease of transcatheter edge-to-edge mitral valve leaflet repair for patients with leaky heart valves. The company positioned its technology as a smaller-footprint alternative to pull-wire, motor-driven, or magnetic catheter control systems. Moray Medical collaborated with industry partners including W. L. Gore's Innovation Center and was backed by early-stage investors. Available company-profile sources indicate the business later became inactive or out of business by late 2025.